Pulse Wave Velocity as Marker of Preclinical Arterial Disease: Reference Levels in a Uruguayan Population Considering Wave Detection Algorithms, Path Lengths, Aging, and Blood Pressure

Table 1

Clinical and hemodynamic characteristics.

Group	10–19 years	20–29 years	30–39 years	40–49 years	50–59 years	60–69 years
𝑁	61	103	60	71	66	68
Age (years)	15±2	24±2^a	34±2^ab	45±3^abc	54±3^abcd	64±4^abcde
Anthropometric measurements
Body height (m)	165±9	167±9	166±9	165±9	165±8	160±10
Body weight (kg)	57±11	63±12	72±16^ab	73±16^ab	71±16^ab	71±12^ab
BMI (kg/m^2)	21±3	23±4^a	26±3^ab	26±3^ab	25±4^ab	27±2^ab
Peripheral hemodynamics parameters
Systolic pressure (mmHg)	118±13	125±12^a	126±14	130±13^ab	132±16^abc	144±19^abcde
Diastolic pressure (mmHg)	64±10	71±8^a	74±11^a	78±9^ab	79±11^ab	75±10^ab
Pulse Pressure (mmHg)	48±6	51±8	53±10	54±8^a	56±9^a	69±13^abcde
Heart rate (bpm)	78±13	73±11	72±8^a	72±12^a	73±12^a	63±10^abcde
Laboratory
Total cholesterol (mg/dL)	183.7±32.1	172.3±23.3	189.3±21.4	184.6±17.0	217.0±8.6^abd	190.4±20.3
HDL-cholesterol (mg/dL)	62.1±7.3	63.4±13.7	66.0±26.6	67.4±6.3	73.2±19.4^ab	65.2±9.6
LDL-cholesterol (mg/dL)	101.2±21.2	90.1±19.3	109.5±28.5	100.9±5.8	126.9±12.2^abd	91.2±12.1^a
Triglycerides (mg/dL)	96.4±47.2	83.2±22.4	56.2±21.0^ab	58.0±2.0^ab	60.2±21.3^ab	64.2±18.0^ab

Mean value ± SD. 𝑁: number of subjects, BMI: body mass index, HDL and LDL: high and low density cholesterol, respectively.
Statistics: ^{a, b, c, d, e} : 𝑃<0.05 with respect to 10–19, 20–29, 30–39, 40–49, and 50–59 years, respectively (ANOVA + Bonferroni Test).